Showing results (51-60 of 257) with videos related to

Sort By:
Pageof 26
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 28, 1992
Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serumK A Yedema, C M Thomas, M F Segers, et al.
Anticancer Research|July 1, 1997
Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancerK N Gaarenstroom, J M Bonfrer, C M Korse, et al.
Obstetrics and Gynecology|November 1, 1983
Epidemiologic features of hydatidiform mole in the NetherlandsH R Franke, E K Risse, P Kenemans, et al.
Gynecologic Oncology|August 1, 1995
Observer agreement on interpreting colposcopic images of CINE H Hopman, F J Voorhorst, P Kenemans, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assaysC Yedema, L Massuger, J Hilgers, et al.
Scanning Electron Microscopy|January 1, 1983
Scanning electron microscopy of exfoliative cervical cytologyR W de Haan, P H van der Zanden, G P Vooys, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
The management of borderline epithelial tumors of the ovaryC. W. Burger, H. M. Prinssen, J. P. A. Baak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1992
Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancerW C Buijs, L F Massuger, R A Claessens, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 22, 1997
[Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast]C W Burger, I Koomen, N A Peters, et al.
Pageof 26